Mphasis Employee Stock Options
Mphasis allotted 64,800 equity shares upon exercise of ESOPs under its 2016 plan. No exercise price or monetary value was disclosed.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Mphasis allotted 64,800 equity shares upon exercise of ESOPs under its 2016 plan. No exercise price or monetary value was disclosed.
Mphasis Limited has allotted 7,800 equity shares upon the exercise of employee stock options under its ESOP 2016 plan.
Mphasis Limited has allotted 700 equity shares following the exercise of Restricted Stock Units (RSUs) by eligible employees under its RSU Plan 2021.
Mphasis Limited has allotted 3,606 equity shares following the exercise of ESOPs and RSUs. This includes 3,400 shares under ESOP 2016 and 206 shares under RSU Plan 2021.
Mphasis Ltd allotted 11,867 equity shares upon exercise of ESOPs and RSUs. This is a routine employee benefit plan execution with no new capital raised.
Mphasis Limited allotted 2,507 equity shares following the exercise of employee stock options and restricted stock units. This routine issuance supports the company's employee incentive schemes.
Mphasis granted 72,010 stock options and 24,000 RSUs to identified employees. These equity-based incentives align employee interests with long-term shareholder value creation.
Mphasis Limited has allotted 39,193 equity shares following the exercise of options under its ESOP 2016 and RSU Plan 2021. The allotment was approved by the ESOP Compensation Committee on May 7, 2026. This routine issuance reflects the conversion of employee stock-based incentives into equity.
Mphasis Limited granted 5,000 stock options to employees under its ESOP 2016 Plan. The options have an exercise price of ₹2,140 each, a 5-year vesting period, and an exercise period of 60 months from vesting.
Mphasis Limited allotted 2,61,697 equity shares during Q4 FY2026 pursuant to its ESOP 2016 Scheme and RSU grants. This allotment increased the company's listed capital to 19,08,19,570 shares. The filing was part of a routine Reconciliation of Share Capital Audit Report submitted under SEBI regulations.